Insulin Pills Closer? Tiny Peptide Solves Gut Barrier

A breakthrough in diabetes treatment may be on the horizon with the development of a novel peptide capable of enabling insulin to pass through the digestive system. This advancement, achieved by a team at Kumamoto University, addresses a critical challenge that has previously prevented the successful development of oral insulin.

Laboratory tests conducted on mice demonstrated that combining this new cyclic peptide with a specially stabilized form of insulin significantly reduced blood sugar levels after oral administration. The peptide helps insulin, typically destroyed by digestion or blocked by the gut lining, to endure the gastrointestinal tract and permeate the intestinal wall.

This research offers a potential solution to the daily burden of insulin injections faced by many individuals. While further investigation is needed to create stable pill formulations, this peptide-insulin combination represents a promising step towards edible insulin therapies. As of 2010, approximately 421,000 individuals in the UK used insulin, a number that has seen significant increases, particularly with rising diagnoses of type 2 diabetes.